CAVO, MICHELE
CAVO, MICHELE
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
Radiologic findings of Fusarium pneumonia in neutropenic patients
In corso di stampa Sassi, Claudia; Stanzani, Marta; Lewis, Russell E.; Vianelli, Nicola; Tarsi, Andrea; Poerio, Antonio; Cavo, Michele; Battista, Giuseppe
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
2024 Hungria V.; Robak P.; Hus M.; Zherebtsova V.; Ward C.; Ho P.J.; Ribas de Almeida A.C.; Hajek R.; Kim K.; Grosicki S.; Sia H.; Bryant A.; Pitombeira de Lacerda M.; Martinez G.A.; Balari A.M.S.; Sandhu I.; Cerchione C.; Ganly P.; Dimopoulos M.; Fu C.; Garg M.; Abdallah A.-O.; Oriol A.; Gatt M.E.; Cavo M.; Rifkin R.; Fujisaki T.; Mielnik M.; Pirooz N.; McKeown A.; McNamara S.; Zhou X.; Nichols M.; Lewis E.; Rogers R.; Baig H.; Eccersley L.; Roy-Ghanta S.; Opalinska J.; Mateos M.-V.
Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
2024 Dimopoulos M.A.; Beksac M.; Pour L.; Delimpasi S.; Vorobyev V.; Quach H.; Spicka I.; Radocha J.; Robak P.; Kim K.; Cavo M.; Suzuki K.; Morris K.; Pompilus F.; Phillips-Jones A.; Zhou X.L.; Fulci G.; Sule N.; Kremer B.E.; Opalinska J.; Mateos M.-V.; Trudel S.
Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma
2024 Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathios; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A.
Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells
2024 Pensato V.; Laginestra M.A.; Falvo P.; Orecchioni S.; Talarico G.; De Marchi E.; Bruno S.; Mongiorgi S.; Mitola G.; Bertolini F.; Adinolfi E.; Cavo M.; Curti A.; Salvestrini V.
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
2024 Sonneveld P.; Dimopoulos M.A.; Boccadoro M.; Quach H.; Ho P.J.; Beksac M.; Hulin C.; Antonioli E.; Leleu X.; Mangiacavalli S.; Perrot A.; Cavo M.; Belotti A.; Broijl A.; Gay F.; Mina R.; Nijhof I.S.; Van De Donk N.W.C.J.; Katodritou E.; Schjesvold F.; Sureda Balari A.; Rosiñol L.; Delforge M.; Roeloffzen W.; Silzle T.; Vangsted A.; Einsele H.; Spencer A.; Hajek R.; Jurczyszyn A.; Lonergan S.; Ahmadi T.; Liu Y.; Wang J.; Vieyra D.; Van Brummelen E.M.J.; Vanquickelberghe V.; Sitthi-Amorn A.; De Boer C.J.; Carson R.; Rodriguez-Otero P.; Bladé J.; Moreau P.
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System
2024 Sparano F.; Giesinger J.M.; Gaidano G.; Anota A.; Cavo M.; Brini A.; Voso M.T.; Venditti A.; Perrone F.; Di Maio M.; Luppi M.; Baron F.; Platzbecker U.; Fazi P.; Vignetti M.; Efficace F.
Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
2024 Delforge M.; Patel K.; Eliason L.; Dhanda D.; Shi L.; Guo S.; Marshall T.S.; Arnulf B.; Cavo M.; Nooka A.; Manier S.; Callander N.; Giralt S.; Einsele H.; Ailawadhi S.; Popa McKiver M.; Cook M.; Rodriguez-Otero P.
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review
2024 Bigi F.; Manzato E.; Barbato S.; Talarico M.; Puppi M.; Masci S.; Sacchetti I.; Restuccia R.; Iezza M.; Rizzello I.; Sartor C.; Mancuso K.; Pantani L.; Tacchetti P.; Cavo M.; Zamagni E.
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial
2024 Mateos M.-V.; Engelhardt M.; Leleu X.; Mesa M.G.; Cavo M.; Dimopoulos M.; Bianco M.; Merlo G.M.; Porte C.L.; Richardson P.G.; Moreau P.
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy
2024 Palandri F.; Palumbo G.A.; Benevolo G.; Iurlo A.; Elli E.M.; Abruzzese E.; Polverelli N.; Tiribelli M.; Auteri G.; Tieghi A.; Caocci G.; Binotto G.; Cavazzini F.; Branzanti F.; Beggiato E.; Miglino M.; Bosi C.; Crugnola M.; Bocchia M.; Martino B.; Pugliese N.; Scaffidi L.; Venturi M.; Duminuco A.; Isidori A.; Cattaneo D.; Krampera M.; Pane F.; Cilloni D.; Semenzato G.; Lemoli R.M.; Cuneo A.; Trawinska M.M.; Vianelli N.; Cavo M.; Bonifacio M.; Breccia M.
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
2024 Rodriguez-Otero, Paula; Usmani, Saad; Cohen, Adam D; van de Donk, Niels W C J; Leleu, Xavier; Pérez-Larraya, Jaime Gállego; Manier, Salomon; Nooka, Ajay K; Mateos, Maria Victoria; Einsele, Hermann; Minnema, Monique; Cavo, Michele; Derman, Benjamin A; Puig, Noemi; Gay, Francesca; Ho, P Joy; Chng, Wee-Joo; Kastritis, Efstathios; Gahrton, Gösta; Weisel, Katja; Nagarajan, Chandramouli; Schjesvold, Fredik; Mikhael, Joseph; Costa, Luciano; Raje, Noopur S; Zamagni, Elena; Hájek, Roman; Weinhold, Niels; Yong, Kwee; Ye, Jing Christine; Sidhana, Surbhi; Merlini, Giampaolo; Martin, Tom; Lin, Yi; Chari, Ajai; Popat, Rakesh; Kaufman, Jonathan L
Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
2024 Richardson, Paul G.; Perrot, Aurore; Miguel, Jesus San; Beksac, Meral; Spicka, Ivan; Leleu, Xavier; Schjesvold, Fredrik; Moreau, Philippe; Dimopoulos, Meletios A.; Huang, Shang-Yi; Minarik, Jiri; Cavo, Michele; Prince, H. Miles; Macé, Sandrine; Zhang, Rick; Dubin, Franck; Morisse, Mony Chenda; Anderson, Kenneth C.
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features
2024 Terragna C.; Poletti A.; Solli V.; Martello M.; Zamagni E.; Pantani L.; Borsi E.; Vigliotta I.; Mazzocchetti G.; Armuzzi S.; Taurisano B.; Testoni N.; Marzocchi G.; Kanapari A.; Pistis I.; Tacchetti P.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.
Plain Language Summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma
2024 Rodriguez-Otero, Paula; Ailawadhi, Sikander; Arnulf, Bertrand; Patel, Krina; Cavo, Michele; Nooka, Ajay K; Manier, Salomon; Callander, Natalie; Costa, Luciano J; Vij, Ravi; Bahlis, Nizar J; Moreau, Philippe; Solomon, Scott R; Delforge, Michel; Berdeja, Jesus; Truppel-Hartmann, Anna; Yang, Zhihong; Favre-Kontula, Linda; Wu, Fan; Piasecki, Julia; Cook, Mark; Giralt, Sergio
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients
2024 Mai E.K.; Hielscher T.; Bertsch U.; Salwender H.J.; Zweegman S.; Raab M.S.; Munder M.; Pantani L.; Mancuso K.; Brossart P.; Beksac M.; Blau I.W.; Durig J.; Besemer B.; Fenk R.; Reimer P.; van der Holt B.; Hanel M.; von Metzler I.; Graeven U.; Muller-Tidow C.; Boccadoro M.; Scheid C.; Dimopoulos M.A.; Hillengass J.; Weisel K.C.; Cavo M.; Sonneveld P.; Goldschmidt H.
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study
2024 Palandri F.; Auteri G.; Abruzzese E.; Caocci G.; Bonifacio M.; Mendicino F.; Latagliata R.; Iurlo A.; Branzanti F.; Garibaldi B.; Trawinska M.M.; Cattaneo D.; Krampera M.; Mulas O.; Martino E.A.; Cavo M.; Vianelli N.; Impera S.; Efficace F.; Heidel F.; Breccia M.; Elli E.M.; Palumbo G.A.
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight
2024 Ielo, Claudia; Fazio, Francesca; Rocchi, Serena; Rizzello, Ilaria; Mancuso, Katia; Zamagni, Elena; Cavo, Michele; Petrucci, Maria Teresa
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients
2024 Borsi, Enrica; Vigliotta, Ilaria; Poletti, Andrea; Mazzocchetti, Gaia; Solli, Vincenza; Zazzeroni, Luca; Martello, Marina; Armuzzi, Silvia; Taurisano, Barbara; Kanapari, Ajsi; Pistis, Ignazia; Zamagni, Elena; Pantani, Lucia; Rocchi, Serena; Mancuso, Katia; Tacchetti, Paola; Rizzello, Ilaria; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Cavo, Michele; Terragna, Carolina
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes
2023 Mongiorgi, Sara; De Stefano, Alessia; Ratti, Stefano; Indio, Valentina; Astolfi, Annalisa; Casalin, Irene; Pellagatti, Andrea; Paolini, Stefania; Parisi, Sarah; Cavo, Michele; Pession, Andrea; McCubrey, James A; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio; Follo, Matilde Y
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Radiologic findings of Fusarium pneumonia in neutropenic patients | Sassi, Claudia; Stanzani, Marta; Lewis, Russell E.; Vianelli, Nicola; Tarsi, Andrea; Poerio, Anto...nio; Cavo, Michele; Battista, Giuseppe | 9999-01-01 | MYCOSES | - | 1.01 Articolo in rivista | - |
| Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma | Hungria V.; Robak P.; Hus M.; Zherebtsova V.; Ward C.; Ho P.J.; Ribas de Almeida A.C.; Hajek R.; ...Kim K.; Grosicki S.; Sia H.; Bryant A.; Pitombeira de Lacerda M.; Martinez G.A.; Balari A.M.S.; Sandhu I.; Cerchione C.; Ganly P.; Dimopoulos M.; Fu C.; Garg M.; Abdallah A.-O.; Oriol A.; Gatt M.E.; Cavo M.; Rifkin R.; Fujisaki T.; Mielnik M.; Pirooz N.; McKeown A.; McNamara S.; Zhou X.; Nichols M.; Lewis E.; Rogers R.; Baig H.; Eccersley L.; Roy-Ghanta S.; Opalinska J.; Mateos M.-V. | 2024-01-01 | THE NEW ENGLAND JOURNAL OF MEDICINE | - | 1.01 Articolo in rivista | - |
| Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma | Dimopoulos M.A.; Beksac M.; Pour L.; Delimpasi S.; Vorobyev V.; Quach H.; Spicka I.; Radocha J.; ...Robak P.; Kim K.; Cavo M.; Suzuki K.; Morris K.; Pompilus F.; Phillips-Jones A.; Zhou X.L.; Fulci G.; Sule N.; Kremer B.E.; Opalinska J.; Mateos M.-V.; Trudel S. | 2024-01-01 | THE NEW ENGLAND JOURNAL OF MEDICINE | - | 1.01 Articolo in rivista | - |
| Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma | Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathi...os; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A. | 2024-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells | Pensato V.; Laginestra M.A.; Falvo P.; Orecchioni S.; Talarico G.; De Marchi E.; Bruno S.; Mongio...rgi S.; Mitola G.; Bertolini F.; Adinolfi E.; Cavo M.; Curti A.; Salvestrini V. | 2024-01-01 | STEM CELLS | - | 1.01 Articolo in rivista | - |
| Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma | Sonneveld P.; Dimopoulos M.A.; Boccadoro M.; Quach H.; Ho P.J.; Beksac M.; Hulin C.; Antonioli E....; Leleu X.; Mangiacavalli S.; Perrot A.; Cavo M.; Belotti A.; Broijl A.; Gay F.; Mina R.; Nijhof I.S.; Van De Donk N.W.C.J.; Katodritou E.; Schjesvold F.; Sureda Balari A.; Rosiñol L.; Delforge M.; Roeloffzen W.; Silzle T.; Vangsted A.; Einsele H.; Spencer A.; Hajek R.; Jurczyszyn A.; Lonergan S.; Ahmadi T.; Liu Y.; Wang J.; Vieyra D.; Van Brummelen E.M.J.; Vanquickelberghe V.; Sitthi-Amorn A.; De Boer C.J.; Carson R.; Rodriguez-Otero P.; Bladé J.; Moreau P. | 2024-01-01 | THE NEW ENGLAND JOURNAL OF MEDICINE | - | 1.01 Articolo in rivista | - |
| Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System | Sparano F.; Giesinger J.M.; Gaidano G.; Anota A.; Cavo M.; Brini A.; Voso M.T.; Venditti A.; Perr...one F.; Di Maio M.; Luppi M.; Baron F.; Platzbecker U.; Fazi P.; Vignetti M.; Efficace F. | 2024-01-01 | JCO ONCOLOGY PRACTICE | - | 1.01 Articolo in rivista | - |
| Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial | Delforge M.; Patel K.; Eliason L.; Dhanda D.; Shi L.; Guo S.; Marshall T.S.; Arnulf B.; Cavo M.; ...Nooka A.; Manier S.; Callander N.; Giralt S.; Einsele H.; Ailawadhi S.; Popa McKiver M.; Cook M.; Rodriguez-Otero P. | 2024-01-01 | THE LANCET. HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review | Bigi F.; Manzato E.; Barbato S.; Talarico M.; Puppi M.; Masci S.; Sacchetti I.; Restuccia R.; Iez...za M.; Rizzello I.; Sartor C.; Mancuso K.; Pantani L.; Tacchetti P.; Cavo M.; Zamagni E. | 2024-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | pharmaceuticals-17-00944.pdf; pharmaceuticals-17-00944-s001.zip |
| Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial | Mateos M.-V.; Engelhardt M.; Leleu X.; Mesa M.G.; Cavo M.; Dimopoulos M.; Bianco M.; Merlo G.M.; ...Porte C.L.; Richardson P.G.; Moreau P. | 2024-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy | Palandri F.; Palumbo G.A.; Benevolo G.; Iurlo A.; Elli E.M.; Abruzzese E.; Polverelli N.; Tiribel...li M.; Auteri G.; Tieghi A.; Caocci G.; Binotto G.; Cavazzini F.; Branzanti F.; Beggiato E.; Miglino M.; Bosi C.; Crugnola M.; Bocchia M.; Martino B.; Pugliese N.; Scaffidi L.; Venturi M.; Duminuco A.; Isidori A.; Cattaneo D.; Krampera M.; Pane F.; Cilloni D.; Semenzato G.; Lemoli R.M.; Cuneo A.; Trawinska M.M.; Vianelli N.; Cavo M.; Bonifacio M.; Breccia M. | 2024-01-01 | CANCER | - | 1.01 Articolo in rivista | Palandri_2024.pdf |
| International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma | Rodriguez-Otero, Paula; Usmani, Saad; Cohen, Adam D; van de Donk, Niels W C J; Leleu, Xavier; Pér...ez-Larraya, Jaime Gállego; Manier, Salomon; Nooka, Ajay K; Mateos, Maria Victoria; Einsele, Hermann; Minnema, Monique; Cavo, Michele; Derman, Benjamin A; Puig, Noemi; Gay, Francesca; Ho, P Joy; Chng, Wee-Joo; Kastritis, Efstathios; Gahrton, Gösta; Weisel, Katja; Nagarajan, Chandramouli; Schjesvold, Fredik; Mikhael, Joseph; Costa, Luciano; Raje, Noopur S; Zamagni, Elena; Hájek, Roman; Weinhold, Niels; Yong, Kwee; Ye, Jing Christine; Sidhana, Surbhi; Merlini, Giampaolo; Martin, Tom; Lin, Yi; Chari, Ajai; Popat, Rakesh; Kaufman, Jonathan L | 2024-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis | Richardson, Paul G.; Perrot, Aurore; Miguel, Jesus San; Beksac, Meral; Spicka, Ivan; Leleu, Xavie...r; Schjesvold, Fredrik; Moreau, Philippe; Dimopoulos, Meletios A.; Huang, Shang-Yi; Minarik, Jiri; Cavo, Michele; Prince, H. Miles; Macé, Sandrine; Zhang, Rick; Dubin, Franck; Morisse, Mony Chenda; Anderson, Kenneth C. | 2024-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features | Terragna C.; Poletti A.; Solli V.; Martello M.; Zamagni E.; Pantani L.; Borsi E.; Vigliotta I.; M...azzocchetti G.; Armuzzi S.; Taurisano B.; Testoni N.; Marzocchi G.; Kanapari A.; Pistis I.; Tacchetti P.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M. | 2024-01-01 | NATURE COMMUNICATIONS | - | 1.01 Articolo in rivista | 41467_2024_Article_45000.pdf; 41467_2024_45000_MOESM7_ESM.zip |
| Plain Language Summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma | Rodriguez-Otero, Paula; Ailawadhi, Sikander; Arnulf, Bertrand; Patel, Krina; Cavo, Michele; Nooka..., Ajay K; Manier, Salomon; Callander, Natalie; Costa, Luciano J; Vij, Ravi; Bahlis, Nizar J; Moreau, Philippe; Solomon, Scott R; Delforge, Michel; Berdeja, Jesus; Truppel-Hartmann, Anna; Yang, Zhihong; Favre-Kontula, Linda; Wu, Fan; Piasecki, Julia; Cook, Mark; Giralt, Sergio | 2024-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients | Mai E.K.; Hielscher T.; Bertsch U.; Salwender H.J.; Zweegman S.; Raab M.S.; Munder M.; Pantani L....; Mancuso K.; Brossart P.; Beksac M.; Blau I.W.; Durig J.; Besemer B.; Fenk R.; Reimer P.; van der Holt B.; Hanel M.; von Metzler I.; Graeven U.; Muller-Tidow C.; Boccadoro M.; Scheid C.; Dimopoulos M.A.; Hillengass J.; Weisel K.C.; Cavo M.; Sonneveld P.; Goldschmidt H. | 2024-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | Mai_2024.pdf; 41375_2023_2105_MOESM1_ESM.pdf |
| Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study | Palandri F.; Auteri G.; Abruzzese E.; Caocci G.; Bonifacio M.; Mendicino F.; Latagliata R.; Iurlo... A.; Branzanti F.; Garibaldi B.; Trawinska M.M.; Cattaneo D.; Krampera M.; Mulas O.; Martino E.A.; Cavo M.; Vianelli N.; Impera S.; Efficace F.; Heidel F.; Breccia M.; Elli E.M.; Palumbo G.A. | 2024-01-01 | ANNALS OF HEMATOLOGY | - | 1.01 Articolo in rivista | Palandri_2024.pdf |
| Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight | Ielo, Claudia; Fazio, Francesca; Rocchi, Serena; Rizzello, Ilaria; Mancuso, Katia; Zamagni, Elena...; Cavo, Michele; Petrucci, Maria Teresa | 2024-01-01 | LEUKEMIA RESEARCH REPORTS | - | 1.01 Articolo in rivista | Severe SARS-CoV-2.pdf |
| Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients | Borsi, Enrica; Vigliotta, Ilaria; Poletti, Andrea; Mazzocchetti, Gaia; Solli, Vincenza; Zazzeroni..., Luca; Martello, Marina; Armuzzi, Silvia; Taurisano, Barbara; Kanapari, Ajsi; Pistis, Ignazia; Zamagni, Elena; Pantani, Lucia; Rocchi, Serena; Mancuso, Katia; Tacchetti, Paola; Rizzello, Ilaria; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Cavo, Michele; Terragna, Carolina | 2024-01-01 | CELLS | - | 1.01 Articolo in rivista | cells-13-00657-v2.pdf; cells-13-00657-s001.zip |
| A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes | Mongiorgi, Sara; De Stefano, Alessia; Ratti, Stefano; Indio, Valentina; Astolfi, Annalisa; Casali...n, Irene; Pellagatti, Andrea; Paolini, Stefania; Parisi, Sarah; Cavo, Michele; Pession, Andrea; McCubrey, James A; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio; Follo, Matilde Y | 2023-01-01 | CLINICAL EPIGENETICS | - | 1.01 Articolo in rivista | s13148-023-01441-9.pdf; 13148_2023_1441_MOESM2_ESM.pdf; 13148_2023_1441_MOESM3_ESM (1).pdf; 13148_2023_1441_MOESM1_ESM.xlsx |